High intensity continuous renal replacement therapy does not improve mortality in critically ill patients

Research output: Contribution to journalComment / DebateOtherpeer-review

Abstract

In critically ill patients with acute kidney injury, high intensity continuous renal replacement therapy (CRRT) (effluent flow rate >25mL/kg/h) shows no benefit on 90-day mortality and is associated with more hypophosphataemia.

Original languageEnglish
Pages (from-to)52-53
Number of pages2
JournalJournal of the Intensive Care Society
Volume11
Issue number1
Publication statusPublished - 1 Jan 2010
Externally publishedYes

Cite this